Truace
Subscribe

Prototype AR glasses with facial recognition for patient verification by urologists

Source article: Utility of Augmented Reality Glasses With Waveguide Optics and Facial Recognition Technology for Patient Verification in a Simulated Outpatient Setting: Physician Questionnaire Survey Study

Background Augmented reality (AR) glasses with waveguide optics and facial recognition may enhance patient identification and clinical workflows. However, their usability among physicians has not yet been evaluated. Objective The objective of this study was to assess the usability and acceptability of prototype AR glasses with facial recognition in a simulated outpatient setting. Methods In May 2025, 14 urologists from a single institution tested prototype AR glasses developed by Cellid Inc. The device incorpora…

By the Truvace desk2 min read1 sourcePeer-reviewedTRV-2026-1368· cite & verify
Utility of Augmented Reality Glasses With Waveguide Optics and Facial Recognition Technology for Patient Verification in a Simulated Outpatient Setting: Physician Questionnaire Survey Study
Granada - Hospital Doctor Olóriz 3 by Zarateman. CC0 · http://creativecommons.org/publicdomain/zero/1.0/deed.en
Trace impact readingContested
P 69The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.

Both sides are scored from claims and sources, not community votes.

G 72The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.

In brief

Fourteen urologists from one institution tried prototype augmented reality glasses in May 2025. The glasses used a camera and deep learning facial recognition to identify preregistered mock patients and showed their demographic and clinical data on the right lens. Afterward the physicians completed an anonymous questionnaire.

The results suggest physicians may accept this kind of tool for patient identification, which could matter for patient safety and workflow. But the evidence is limited to a small, single-institution simulation measuring perceptions, so real clinical benefit, accuracy and safety remain untested.

Main points

  1. Eleven of 14 participants (79%) found the device helpful in performing clinical procedures.
  2. Twelve participants (86%) believed it improved patient safety.
  3. Four of 13 respondents reported somewhat tired eyes, and one had minor transient headache and nausea.
  4. Four of the 5 participants who wore prescription glasses had difficulty wearing the prototype over them.
  5. Eight of 13 respondents rated the displayed patient information as slightly difficult to see.

The gain

In a simulated outpatient setting, most urologists who tested the prototype said it helped with clinical procedures and improved patient safety, and many would use it in future practice.

The problem

Some physicians reported eye fatigue, heaviness, difficulty wearing the device over prescription glasses, and hard-to-read patient information on the display.

The rundown

The device was developed by Cellid Inc. and combines waveguide-based optical displays, a miniature camera, and deep learning-based facial recognition software. Physicians identified preregistered mock patients, with data shown on the right lens.

Outcomes came from an anonymous questionnaire covering usability, comfort, visibility and self-reported symptoms on 3- or 5-point Likert scales. Most participants adapted quickly to wearing the glasses, and visibility of the surroundings and perceived facial recognition responsiveness were generally favorable.

Comfort issues included slight heaviness reported by 3 of 13 respondents and eye fatigue. The authors conclude the glasses were well accepted in this pilot but need further refinement and larger clinical evaluations.

What this doesn’t fix

This was a small pilot with 14 urologists from a single institution in a simulated setting, relying on self-reported questionnaire responses, so the authors say further refinement and larger clinical evaluations are needed.

Sources

  1. Peer-reviewedJMIR Human Factors2026-10-02

The debate